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Milwaukee, Wisconsin
The electrophysiologic effects of intravenous verapamil
(0.15 ml/kg) on retrograde atrioventricular (AV) nodal
conduction were studied in 17 patients who had no evi-
dence of supraventricular reentrant tachycardia, de-
monstrable dual AV nodal refractory period curves or
accessory pathways. Using the His bundle electrogram,
incremental ventricular pacing and the ventricular ex-
trastimulus (V2) technique, the ventriculoatrial (VA),
retrograde His-Purkinje system (V2H2) and AV nodal
conduction (H2A2) times were measured before and after
treatment with verapamil.
With incremental ventricular pacing during the con-
trol period, the cycle length that produced VA block
ranged from 260 to 520 ms (mean ± standard deviation
337.0 ± 67.8 ms). After the administration ofverapamil,
VA conduction was abolished in 2 patients, and in 12
patients the mean ventricular pacing cycle length pro-
ducing VA block increased from 305.0 ± 35.7 ms during
Previous studies (1-6) have shown that atrioventricular (AV)
nodal cells manifest calcium-dependent "slow channel"
conduction characteristics. Verapamil is known to inhibit
the calcium-dependent slow channel response, and thereby
slow AV nodal conduction and prolong AV nodal refrac-
toriness (7-9). Although the electrophysiologic effects of
verapamil on the functional properties of the AV node in
the anterograde direction have been extensively studied (10-
13), the effect of this drug on retrograde AV nodal con-
duction and refractoriness in human subjects in unknown.
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the control period to 413.3 ± 66.8 ms (p < 0.0001) after
verapamil. In the remaining three patients, verapamil
had no effect on the onset of pacing-induced VA block.
Following V2 during the control period, the retrograde
His deflection (H2) emerged from the local ventricular
electrogram and retrograde atrial activation occurred
via the His bundle in all patients. The control H2A2
intervals ranged from 30 to 150 ms. After verapamil,
retrograde AV nodal block (that is, H2 but no A2) oc-
curred in 7 of 17 patients, and H2A2intervals were pro-
longed by a mean of 18.3 ± 5.5 ms (range 10 to 25) in
another 6 patients. The H2A2 intervals did not change
in the remaining four patients after administration of
verapamil.
The results show that verapamil exerts a depressant
effect on retrograde AV nodal conduction in the majority
of patients, including those with rapid conduction.
This study, therefore, was undertaken to examine the re-
sponse of retrograde AV nodal conduction to verapamil.
Methods
Patients. Seventeen consecutive patients with intact
ventriculoatrial (VA) conduction who received verapamil
were included in this study. There were 11 men and 6
women whose age ranged from 32 to 73 years (mean ±
standard deviation [SO] 55.7 ± 10.5). The patients were
studied because of syncope, dizziness or ventricular ar-
rhythmias. Ten patients had arteriosclerotic heart disease,
one had mitral valve prolapse and two had cardiomyopathy.
The remaining four patients had no clinically detectable
structural heart disease. Electrophysiologic studies were
performed in the postabsorptive state. None of the patients
were taking cardioactive medication at the time of this study.
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The nature of the procedure was explained and informed
consent was obtained.
Electrophysiologic studies. Multipolar electrode cath-
eters were introduced percutan eously under local anesthesia
and were positioned with fluoroscopic guidance into the high
right atrium , AV junction and right ventricle to record local
electrical activity or local electrical stimulation. All intra-
cardiac electrograms (filtered at 30 to 500 Hz frequency ),
three surface electrocardiograph ic leads and time lines were
simultaneously displayed on a multichannel oscilloscope
and recorded on magnetic tape for later reproduction. Pro-
grammed electrical stimul ation was done using a digital
stimulator (Bloom Associates) , delivering rectangular im-
pulses with adjustable amplitude and duration. During these
studies, patients were isolated electrically and all equipment
was grounded at equipotential.
In all the patients the f ollowing electrical stimulation
protocol was used: I) incremental atrial pacing to achieve
the anterograde AV nodal Wenckebach phenomenon; 2)
anterograde refractory period determination using atrial basic
drive (AlAI) followed by premature atrial stimulation (A z);
3) incremental ventricular pacing to achieve ventriculoatrial
(VA) block ; and 4) retrograde refractory period studies using
ventricular basic drive (SIS Ior VIVI) followed by premature
ventricular stimulation (Sz or Vz).
Definitions and measurements. Complete definitions
for anterograde and retrograd e conduction times and re-
fractory periods have been published (14). Pertinent defi-
nitions used in this report are described below .
The AH interval was measured from the onset of the low
atrial electrogram to the beginning of the His (H) bundle
potential.
Retrograde conduction: The VA (or SA) interval was
measured from the corresponding stimulus artifact to the
onset of the low right atrial deflection of the His bundle
electrogram. After the retrograde Hz deflection emerged
from the local Vz- retrograde His-Purkinje conduction times
were measured from the corresponding stimulus artifact to
the onset of the retrograde Hz deflection. The retrograde
AV nodal conduction time was measured from both the onset
and the end of Hz to the beginning of the Az deflection on
the His bundle electrogram.
Retrograde refractory periods: fun ctional refractory pe-
riod (FRP) of the His-Purkinje system: This was defined as
the shortest SIHz (or VIHz) interval in response to a full
range of S,S z interval s.
Effective refra ctory period of the AV node: This was
defined as the longest S,Hz (or V.H z) interval where Hz was
not followed by Az. V ,Hz is taken in lieu of retrograde H,Hz
because retrograde HI is generally not visible during the
basic drive and the rationale of using VIHz instead has been
previously described (14,15 ).
Effective refra ctory period of His-Purkinje system: This
was defined as the longest VIVz interval where Vz blocked
below the His bundle recording site .
Effective refractory period of ventricular myocardium :
This was defined as the longest StS Z interval at which Sz
failed to depolarize the ventricle .
Intravenous verapamil. After initial studies , all pa-
tients received verapamil, 0.15 mg/kg intravenou sly, while
the blood pressure was carefully monitored and no signif-
icant hypotension (that is, > 20 mm Hg decre ase in systolic
blood pressure) was encountered . In all cases, the identical
protocol was repeated and completed within 15 minutes of
verapamil administration .
Pharmacokinetics of verapamil. Previous studies have
shown that a single intravenou s dose of verapamil has a
biphasic mode of distribution in the body , the half-life of
the initial phase being 18.5 to 30 minutes. The hemody-
namic effects are of short duration , lasting approximately
10 minutes, but the electrophysiologic effect s, while max-
imal within 2 to 3 minutes of infusion, are still significant
after 20 minutes (10). Verapamil plasma levels were not
measured in this study . However , because the repeat pro-
tocol was completed within 15 minutes of administering
verapamil, the results should reflect the electrophysiologic
effect of the drug (16-19).
Statistical analysis. Mean values are expressed with
corresponding standard deviations. Compari son of mean
values was done using the paired t test. Stati stical signifi-
cance was defined at the 5% level.
Results
All patients were in sinus rhythm and had normal AH
and HV intervals. Relevant data are described in detail below.
Anterograde conduction times and refractory periods.
The effects of intravenou s verapamil on sinus cycle length,
anterograde conduction time and refractory periods were
similar to those previou sly published (10-12,18). The mean
control spontaneous sinus cycle length was 777.0 ± III
ms (range 610 to 1,090), which prolonged to a mean of
818.2 ± 128 ms (range 670 to 1,120) after verapam il (prob-
ability [p) = not significant).
The mean AH interval during sinus rhythm was 102.0
± 23.5 ms (range 80 to 140), which prolonged to a mean
of 137.3 ± 26.9 ms (range 100 to 190) after verapamil (p
< 0.01). The HV interval during sinus rhythm had a mean
value of 41.4 ± 5.2 ms (range 35 to 50) before and 42.0
± 5.0 ms (range 35 to 50) after verapamil (p = not sig-
nificant). The atrial pacing cycle length that produ ced AV
nodal Wenckebach phenomenon measured 359.4 ± 82.6
ms (range 300 to 600) during the control period , which
increased to a mean of 432.9 ± 91.1 ms (range 330 to 650)
after verapamil (p < 0.001 ). The functional refracto ry pe-
riod of the AV node before drug administration was 414.1
± 54.0 ms (range 314 to 520). which increased to a mean
of 470 ± 582 ms (range 400 to 580) after the drug (p <
0.001) . The AV nodal effective refractory period could be
lACC Vol 2. No 3
September 1983 545- 50
SHENASA ET AL.
VERAPAMIL AND RETROGRADE CONDUCTION
547
measured in II of 17patients beforeand afteradministration
of verapamil and was 318 ± 58.1 ms (range 240 to 410)
and 374 ± 63.6 ms (range 300 to 480), respectively (p <
0.00 I). In the remaining sixpatients, theeffecti ve refractory
period of the atrium was reached before that of the AV
node. The control effective refractory period of the atrium
did not change significantly after administration of vera-
pamil (239.3 ± 28.8 and 245.6 ± 27.3 ms during the
control period and after verapamil , respectively).
Retrograde conduction times (Table 1). For the entire
group, the mean paced cycle length resulting in ventricu-
loatrial (VA) block during the control period was 337.0 ±
67.8 ms (range 260 to 520). After administration of vera-
pamil, VA conduction was abolished in 2 patients (Cases
15 and 16), and in 12 patients (Cases 1,2,4 to 12 and 14),
the mean cycle length that produced VA block increased
from 305.0 ± 35.7 to 41 3.3 ± 66.8 ms (p < 0.0001 ) (Fig.
I). In the remaining three patients (Cases 3,13 and 15),
verapamil produced no detectable change.
During the control study, the mean value for the shortest
VA intervals in these 17 patients was 167.7 ± 36.4 ms
(range 110 to 240). Before drug administration, the VA
intervals stayed constant in 3 patients (Cases 3,4 and II ),
whereas lengthening of the VA interval was noted in the
remaining 14 as the paced cycle length was shortened. The
magnitude of change in the VA interval from longest to
shortest paced cycle lengths with I:I response in these 14
cases ranged from 10 to 140 ms (mean 40.0 ± 34.2).
After administration of verapamil, the VA intervals could
not be measured in two patients (Cases 16 and 17) because
of the onset of complete VA block. The site of retrograde
block and concealed conduction was the AV node, as sug-
gested by intranodal delay and block of dissociated sinus
beats. Fourpatients (Cases 3,9, 13 and 15) showed no change
in either the shortest or the longest VA interval after vera-
pami!. In the remaining II patients, the shortest and longest
VA intervals increased by 20.4 ± II. 3 ms (range 10 to
40) and 27.7 ± 15.2 ms (range 10 to 60), respectively,
after verapami!.
Retrograde refractory period studies (Table 1). During
the control period, the VzAz response in all patients was
typical of retrograde conduction by way of the normal path-
way, that is, the retrograde Az response was dependent on
Hz activation. Progressive shortening in the VIVz intervals
produced a progressive increase in VzAz. Within a certain
range of VIV2, the retrograde His bundle potential (Hz)
emerged from the local V2 electrogram, permitting sepa-
ration of the retrograde His-Purkinje system time (SzH2 or
VzHz interval) from the retrograde AV nodal (HzAz) con-
duction time. The retrograde His-Purkinje system and AV
nodal conduction responses to verapamil are shown sepa-
rately in this report.
Retrograde AV nodal conduction . The control HzAz
intervals were relatively short (:::;;50 ms) and constant in II
patients (Cases 1 to II ), of medium duration (~ 55 but
:::;;\00 ms) in 4 (Cases 12 to IS) and long (~ 100 ms) in
the remaining 2 (Cases 16 and 17). None of our patients
exhibitedretrogradeblock in the AV nodeduringventricular
premature stimulation at any of the coupling intervals. After
administration of verapamil , VA conduction during the basic
drive (VIAl) remained intact in 15 patients and was abol-
ished in 2 (Cases 16 and 17). In the latter two patients, it
Table 1. Retrograde Conduction Times and Refractory Periods
CLof VA Shortest VA Longest VA Longest Shortest HzAz Shortest HzAz Shortest ERP-VM
Block (rns) S-LRA (rns) S-LRA (rns)
BaSICDrive
SzHz (ms) Onset (ms) End (rns) SIHz (ms) (ms)
Case C V C V C V (S\Sz) (ms) C V C V C V C V C V
I 320 510 170 185 240 300 600 190 180 40 55 30 45 380 390 210 210
2 300 430 140 165 170 190 600 170 180 40 Blocked 20 Blocked 440 420 200 200
3 440 440 180 180 180 180 600 280 280 45 45 30 30 580 570 21 0 21 0
4 260 320 110 125 11 0 125 600 280 275 50 65 30 40 41 0 420 200 200
5 300 420 160 180 170 195 600 255 250 50 Blocked 40 Blocked 41 0 410 230 230
6 330 470 140 160 190 225 600 140 140 50 75 40 64 420 420 240 250
7 370 410 240 250 380 400 600 21 0 21 0 45 65 30 55 460 460 240 240
8 290 480 120 160 140 180 600 200 200 45 Blocked 30 Blocked 430 420 240 240
9 260 320 190 190 220 220 700 21 0 210 40 40 30 45 430 430 200 190
10 340 420 200 230 210 240 600 210 210 35 Blocked 50 Blocked 470 470 210 21 0
11 260 320 230 240 230 240 600 210 210 30 40 20 20 450 450 230 230
12 350 480 190 220 250 290 600 240 240 80 105 60 80 480 490 240 240
13 340 340 220 220 260 260 700 190 180 75 75 60 60 420 420 230 220
14 280 380 160 170 170 180 500 180 180 80 Blocked 70 Blocked 440 440 220 220
15 340 340 170 170 200 200 600 270 270 95 95 11 5 115 41 0 400 190 190
16 400 No VA 200 No VA 220 No VA 600 220 220 105 Blocked 170 Blocked 440 450 240 240
17 520 No VA 185 No VA 225 No VA 600 190 190 150 Blocked 170 Blocked 490 490 240 240
C = control study. CL '" cycle length; ERP-VM = effective refractory period of ventncular myocardium; S-LRA = stimulus-low nght atrium
interval; V = after administration of veraparrul : VA = ventnculoatnal.
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Figure 1. Patient 8: Ventriculoatrial block after
verapamil. Tracings from top to bottom are
electrocardiographic lead VI, high right atrial elec-
trogram (HRA), His bundle electrogram (HB) and
time lines (T). Panel A shows I: I retrograde con-
duction during the control period at a ventricular
paced cycle length (VCL) of 300 ms. After vera-
pamil (panel B), ventriculoatrial block occurs at a
VCL of 480 ms. Note that the AH interval during
sinus rhythm is longer after verapamil than during
the control period. A = atrial activation of sinus
origin; Ar = retrograde atrial activation; S = stim-
ulus artifact; V = ventricular electrogram.
could be directly documented with V2 that the site of block
was above the His bundle recording site. In 5 of the 15
patients with intact VIAl (Cases 2,5,8,10 and 14), the V2
showed a retrograde block in the AV node (that is, H2 but
no A2) (Fig. 2). Another six patients (Cases 1,4,6,9 and
12) demonstrated prolongation of the H2A2 interval by a
mean of 18.3 ± 5.5 ms (range to to 25) after administration
of verapamil. In the remaining four patients (Cases 3, 11,13
and 15), verapamil had no effect on H2A2 conduction.
Retrograde His-Purkinje system conduction. Vera-
pamil produced no significant effect on this value. The long-
est S2H2 intervals before and after verapamil were 214.4 ±
39.3 ms (range 140 to 280) and 213.2 ± 38.8 ms (range
140 to 280), respectively. Similarly, the retrograde func-
tional refractory period of the His-Purkinje system did not
change significantly after verapamil, and the values were
444.7 ± 44.7 ms (range 380 to 560) before and 444.1 ±
43.4 ms (range 390 to 570) after, respectively, for all 17
patients. The effective refractory period of ventricular myo-
cardium also did not change and the mean values were 221.8
± 17.8 ms and 221.2 ± 19.3 ms, respectively, before and
after verapamil.
Discussion
Effect of verapamil on retrograde AV nodal conduc-
tion. The data presented here suggest that verapamil con-
sistently produces a depressant effect on ventriculoatrial
(VA) conduction through the normal pathway (that is, AV
node-His-Purkinje system). Because no direct depressant
action of verapamil has been demonstrated on His-Purkinje
system conduction times or refractoriness, the logical in-
ference is that the observed changes were confined to the
AV node (20). The latter conclusion could also be directly
documented in this study during ventricular premature stim-
ulation, which showed that the conduction delay or block,
or both, after administration of verapamil was always above
the site of the His bundle recording. Verapamil also uni-
formly produced the expected increases in anterograde AV
nodal conduction time and refractoriness (18). In this study,
no appreciable changes in atrial or ventricular refractoriness
were observed after administration of verapamil.
In individual patients, the magnitude of depression in
AV nodal conduction was not predictable. It was noted,
however, that the two patients who developed complete VA
block (AV dissociation) after verapamil had the longest
H2A2 intervals (l05 and 150 ms) before administration of
the drug. In the remaining patients, the degree of depressant
effect (delay or block) was comparable; that is, patients with
short or medium range H2A2 intervals showed a similar
magnitude of change. Interestingly, of the four patients with
no change in H2A2 conduction, two had relatively short (40
and 45 ms) H2A2intervals and the remaining two had values
in the medium range (75 and 95 ms).
Effect on AV nodal versus His-Purkinje conduction.
Although the retrograde His deflection was not clearly iden-
tifiable during incremental ventricular pacing, the change
in the VA intervals with incremental pacing after verapamil
was most probably due to an increase in the AV nodal (HA)
rather than the His-Purkinje system (SH) conduction time.
This can be safely deduced from the following observations:
l) no change in His-Purkinje system conduction times or
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Figure 2. Patient 8: Effect of verapamil during
ventricular premature stimulation. The tracing de-
picts introduction of premature ventricular stimu-
lation (Vz) at a basic cycle lengthof 600 ms during
the control period (panel A) and after verapamil
(panel B). The HzAz interval is relatively short
before verapamil, but after the drug, the impulse B
blocks in the atrioventricular node (that is, Hz, but
not Az in panel B, even at a significantly longer
V1Hz interval).
A
S,S2'320
S2H2'130
S,H2'450
---s,fYIC_"-sdJ\V\,\.,.lS~2--:,~VII.2~H~2 -./V--+1ill-- -..II'"'H\..-
sll '1"600 s,/11r 600 s,/I'
refractory periods was noted after administration of vera-
pamil in this study; and 2) patients who did not manifest
any increase in the VA intervals afterthe drug (Cases 3,9,13
and 17) also did not demonstrate an increase in the HzAz
intervals. Because blood levels were not measured during
this study, one might argue whether blood levels in these
four patients were sufficiently high. However, these patients
manifested an appropriate increase in anterograde AV nodal
conduction, which is a more significant manifestation of
cardiac drug effect than the blood levels.
Electrophysiologic significance. A depressant response
to verapamil in patients with long HzAz intervals is not
surprising because in these cases, the retrograde conduction
would be considered typically AV nodal, that is, long HzA2
intervals and onset of VA block at relatively long paced
cycle lengths of 520 and 400 ms, respectively (14). How-
ever, verapamil produced a similar depressant effect in 9
of 11 patients with short (:s; 50 ms) HzAz intervals. Ac-
cepting the prevailing view that the depressant effect of
verapamil on the AV node is secondary to its calcium chan-
nel blocking properties, it would seem that the short HzA2
intervals are compatible with intranodal conduction. There-
fore, one need not invoke the presence of AV nodal bypass
tracts to explain the relatively rapid HA conduction in this
group of patients (21,22).
A complete lack of depressant effect on H2A2 conduction
seen in four patients, however, is puzzling. One possible
explanation is that the reflex sympathetic stimulation after
administration of verapamil may have nullified the depres-
sant effect of drug on the AV node (17-19). However, the
hypotension in these patients with verapamil or ventricular
pacing, or both, was no greater than in the rest of the
patients. Furthermore, no other evidence of excessive sym-
pathetic stimulation, such as sinus acceleration and short-
ening of AH intervals (or lack of AH prolongation), was
noted. Verapamil- or pacing-induced sympathetic stimula-
tion, or both, therefore does not appear to be a rational
explanation for fixed H2Az intervals in these cases. Another
possibility is that the lack of H2A2 prolongation represents
conduction by way of a complete AV nodal bypass (atrio-
His) tract rather than the AV node (22). Although this hy-
pothesis is quite conceivable, it is noteworthy that control
HA conduction times in two of these four patients cannot
be considered rapid and thus, of themselves, are not sugges-
tive of conduction by way of an AV nodal bypass tract.
Perhaps the differences in responsiveness to verapamil in
the anterograde and retrograde directions in these four pa-
tients are related to physiologic rather than anatomic factors
that have been previously postulated and are, therefore, not
discussed in detail here (23-26).
Clinical implications. Although patients with AV nodal
reentrant tachycardia were specificially excluded from this
study, the retrograde conduction patterns in 15 of the 17
patients (except Cases 16 and 17) were quite similar to those
in patients with common AV nodal reentry (27). In patients
with common AV nodal reentry, verapamil is expected to
produce a depressant effect on the anterograde limb of the
circuit (the so-called slow pathway). The results of our study
suggest that verapamil may abo produce a depressant effect
on the retrograde fast pathway of the reentrant circuit.
550 SHENASA ET AL.
VERAPAMIL ANDRETROGRADE CONDUCTION
JACC Vol 2. No. 3
September 1983:545-50
References
I. TritthartH, FleckensteinB, FleckensteinA. Some fundamental actions
of antiarrhythmic drugs on the excitability and the contractility of
smgle myocardial fibers. Naunyn Schmiedebergs Arch Pharmacol
1971;269:212- 9.
2. Kohlhardt M, Bauer B, Krause H. Differentiation of the transmem-
brane Na and Ca channels in mammalian cardiac fibers by the use of
specific inhibitors. Pflugers Arch Gesamte Physiol 1972;335:309-22 .
3. Rosen MR, Ilventro lP , Merker C. The electrophysiologic basis for
the suppression of cardiac arrhythmias by verapamil (abstr), Am 1
Cardiol 1974;33:166.
4. Cranefield PF, Aronson RS, WitAL. Effectof verapamilon the normal
action potential and on calcium-dependent slow response of canine
cardiac Purkinje fibers. Circ Res 1974;34:204-13.
5. Wit AL, Cranefield PF. Effect of verapamil on the sinoatrial and
atrioventricular nodes of the rabbit and the mechanism by which it
arrests reentrant atrioventricular nodal tachycardia. Circ Res
1974;35:413-25.
6. Zipes DP, Fischer lC . Effects of agents which inhibit the slowchannel
on sinus node automaticity andatrioventricularnodal tachycardia. Circ
Res 1974;34:184- 92.
7. Mangiardi LM, Hariman Rl, McAllister RG, Bhargava V, Surawicz
B, Shabetai R. Electrophysiologic and hemodynamic effects of vera-
pamil. Correlation with plasma drug concentrations. Circulation
1978;57:366-72.
8. Sung Rl, Elser B, McAllister RG. Intravenous verapamil for termi-
nation of reentrant supraventricular tachycardias. Intracardiae studies
correlated with plasma verapamil concentrations. Ann.Intern Med
1980;93:682- 9.
9. Rinkenberger RL, Prystowsky EN, Heger 11 , TroupPl , Jackman WM,
Zipes DP. Effects of intravenous and chronic oral verapamil admin-
istration in patients with supraventricular tachyarrhythmias. Circula-
tion 1980;62:996- 1010.
10. Roy PR, Spurrell RA1 , Sowton E. The effect of verapamil on the
cardiac conduction system in man. Postgrad Med 1 1974;50:270- 1.
II. Krikler D. Verapamil in cardiology. Eur 1 Cardiol 1974;2:3- 10.
12. Singh BN, Ellrodt G, Peter CT. Verapamil: a review of its pharrna-
cological properties and therapeutic use. Drugs 1978;15:169-97.
13. ZipesDP, Troup Pl . New antiarrhythmic agents. Amiodarone, aprin-
dine, disopyramide, ethmozin, rnexiletine, tocainide, verapamil. Am
1 Cardiol 1978;41:1005-24.
14. Akhtar M, Damato AN, Batsford WP, Ruskin IN, Ogunkelu JB.
Comparative analysis of anterograde and retrograde conduction m
man. Circulation 1975;52:766-7 8.
15. Akhtar M, Damato AN, Ruskin IN, et al. Characteristics and coex-
istence of two forms of ventricular echo phenomena. Am Heart 1
1976;92:174-82.
16. Schomerus M, Spiegelhalder B, Stieren B, Eichenlbaum M. Phys-
iologicaldisposition of verapamil in man. Cardiovasc Res 1976;10:605-
12.
17. Singh BN, Roche AHG. Effects of intravenous verapamil on hemo-
dynamics m patients with heart disease. Am Heart 1 1977;94:593-9.
18. Husaini MH, Kvasnicka 1, RydenL, Holmberg1. Action ofverapamil
on sinus node, atnoventricular and intraventricular conduction. Br
Heart 1 1973;35:734-7.
19. McAllister RG, Kirsten EB. The pharmacology of vcraparml, IV.
Kinetic and dynamic effects after single intravenous and oral doses.
Cltn Pharmacol Ther 1982;31:418-26.
20. Reddy CP, Kuo CS, Atarashi H, Surawicz B, McAllister RG. Absence
of slowchannel-dependent conduction withinthe His-Purkinje (bundle
branch) reentrant circuit: a cluneal and experimental study of the
effects of verapamil. Am J Cardiol 1982;49:724-32.
21. Gomes lAC, Dhatt MS, Damato AN, Akhtar M, Holder CA. Inci-
dence, determinants and significance of fixed retrograde conduction
inthe region of the atrioventncular node. Am1Cardiol 1979;44:1089-
98.
22. Narula OS. Paroxysmal supraventricular tachycardia due to recnpro-
cation via concealed accessory pathways. In: Cardiac Arrhythmias:
Electrophysiology, Diagnosis and Management. Baltimore, MD: Wil-
liams & Wilkins 1979:272- 293.
23. de la Fuente D, Sasyniuk B. Moe GK. Conduction through a narrow
isthmus in isolated carune atrial tissue. Circulation 1971 :44:803-9.
24. Van Capelle FJL, Anse 1M. Influence of geometry on the shape of
the propagated action potential. In: Wellens H11 , Lie KI, l anse Ml,
cds. The Conduction System of the Heart: Structure, Function and
Clinical Implications. Philadelphia: Lea & Febiger, 1976;316-35.
25. Downer E, Waxman MB. Depressed conduction and unidirectional
block in Purkinje fibers. In Ref 24:393-409.
26. Shenasa M, Gilbert C, Schmidt DH, Akhtar MS. Procainamide and
retrograde atrioventricular nodal conduction in man. Circulation
1982;65:355-61.
27. Akhtar M, Damato AN, Ruskin lN, et al. Antegrade and retrograde
conduction characteristics in three patterns of paroxysmal atrioven-
tricular junctional reentrant tachycardia. Am Heart 1 1978;95:22-42.
